CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2b, Randomized, Double-Mask, Placebo-Controlled, Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05276063
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:56.403148+00:00
Published At: 2025-01-29T00:00:00+00:00
Record Updated At: 2025-01-29
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Thyroid Eye Disease", "Graves Orbitopathy", "Endocrine System Diseases", "Eye Diseases", "Thyroid Associated Ophthalmopathy", "Graves Ophthalmopathy", "Thyroid Diseases", "Orbital Diseases", "Proptosis", "IGF1R", "Exophthalmos", "Hashimoto"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-01-29"
protocolSection.identificationModule.nctId: "NCT05276063"
protocolSection.identificationModule.officialTitle: "A Phase 2b, Randomized, Double-Mask, Placebo-Controlled, Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE2", "PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.